It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The Golgi is a dynamic organelle whose correct assembly is crucial for cellular homeostasis. Perturbations in Golgi structure are associated with numerous disorders from neurodegeneration to cancer. However, whether and how dispersal of the Golgi apparatus is actively regulated under stress, and the consequences of Golgi dispersal, remain unknown. Here we demonstrate that 26S proteasomes are associated with the cytosolic surface of Golgi membranes to facilitate Golgi Apparatus-Related Degradation (GARD) and degradation of GM130 in response to Golgi stress. The degradation of GM130 is dependent on p97/VCP and 26S proteasomes, and required for Golgi dispersal. Finally, we show that perturbation of Golgi homeostasis induces cell death of multiple myeloma in vitro and in vivo, offering a therapeutic strategy for this malignancy. Taken together, this work reveals a mechanism of Golgi-localized proteasomal degradation, providing a functional link between proteostasis control and Golgi architecture, which may be critical in various secretion-related pathologies.
Correct Golgi assembly is important to cellular homeostasis but regulation of its structure under stress remains unclear. Here, the authors identify stress-induced degradation of GM130 by Golgi-localized 26S proteasomes, leading to Golgi dispersal.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Weizmann Institute of Science, Department of Immunology, Rehovot, Israel (GRID:grid.13992.30) (ISNI:0000 0004 0604 7563)
2 University of Michigan, Department of Molecular, Cellular and Developmental Biology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
3 Weizmann Institute of Science, Department of Chemical Research Support, Rehovot, Israel (GRID:grid.13992.30) (ISNI:0000 0004 0604 7563)
4 Weizmann Institute of Science, Department of Biomolecular Sciences, Rehovot, Israel (GRID:grid.13992.30) (ISNI:0000 0004 0604 7563)
5 Weizmann Institute of Science, Flow Cytometry Unit, Life Sciences Core Facilities, Rehovot, Israel (GRID:grid.13992.30) (ISNI:0000 0004 0604 7563)